Whalesbook
India's drug regulator plans to amend the Drugs and Cosmetics Rules, requiring drug marketers to obtain a license before selling or distributing medicines. This move aims to tighten oversight on marketers, ensuring accountability for drug quality, safety, and efficacy, and will impact both domestic and multinational pharmaceutical companies.